OpenEquity Research
  • Home
  • News
No Result
View All Result
Request Research
  • Home
  • News
No Result
View All Result
OpenEquity Research
No Result
View All Result

Mill City Funds $855,000 Short-Term Insurance Settlement

by
November 3, 2022

MINNEAPOLIS, Minn., November 3, 2022 – Mill City Ventures III, Ltd. (“Mill City” or the “Company”) (Nasdaq: MCVT) announced today its funding of a settled insurance claim in the amount of $855,000. The related short-term note is expected to mature in 120 days and involve an annualized return of 33.5%.

Mill City Chief Executive Officer, Douglas M. Polinsky, said, “This latest closing is one more example of our ability to profitably service a growing need in the financing markets. With rising inflation and rapidly rising interest rates, borrowers are facing an increasing number of hurdles to clear in their efforts to access capital on a short-term basis. There continues to be a large funding gap between the needs of small- and medium-sized businesses and the institution-based financing available to them. Our ability to quickly create financing solutions for a variety of needs is proving to be a significant growth engine for Mill City Ventures.”

About Mill City

Founded in 2007, Mill City is a short-term non-bank lending and specialty finance company. Additional information can be found at www.sec.gov.

Forward-Looking Statements and Safe Harbor Notice

All statements other than statements of historical facts included in this press release are "forward-looking statements" (as defined in the Private Securities Litigation Reform Act of 1995). Such forward-looking statements include our expectations and those statements that use forward-looking words such as "projected," "expect," "possibility" and "anticipate." The achievement or success of the matters covered by such forward-looking statements involve significant risks, uncertainties and assumptions. Actual results could differ materially from current projections or implied results. Investors should carefully read the risk factors set forth in the Company's prospectus contained within the Form S-1 filed with the SEC on April 26, 2022, as amended, subsequent filings and future periodic reports filed with the SEC. All of the Company's forward-looking statements are expressly qualified by all such risk factors and other cautionary statements.

The Company cautions that statements and assumptions made in this press release constitute forward-looking statements and make no guarantee of future performance. Forward-looking statements are based on estimates and opinions of management at the time statements are made. The information set forth herein speaks only as of the date hereof. The Company and its management undertake no obligation to revise these statements following the date of this news release, other than as required by law.

Contact:

Joseph A. Geraci, CFO

952-479-1920

Investor Contact:

TraDigital IR

John McNamara

917-658-2602

john@tradigitalir.com

Previous Post

Brüush Appoints New Vice President of Sales & Business Development

Next Post

CDSCO India equivalent to US FDA approves Photocil for Sale

Next Post
Eris Oaknet Healthcare and Cosmofix Technovation Announce Market Launch of Jupiter Wellness’s Photocil Products for Indian Market cover

CDSCO India equivalent to US FDA approves Photocil for Sale

Subscribe

CONGRATULATIONS!!

These Next Steps are EXTREMELY IMPORTANT because the only way to get our Featured Top Stock Alerts is to reply back to the message you just received by answering YES.

CLICK HERE TO REPLY BACK
YES ON YOUR CELL PHONE

To make sure you are in, please check your cell phone for a message from 16462224464 (make sure you save that number on your contacts under "StockTips") If you don't see the message check "Unknown Senders" on your phone.

If you did not receive the text message on your cell phone, then grab your phone right now and text the word "MOMO" to "16462224464"

  • United States+1
  • Bangladesh (বাংলাদেশ)+880
  • Germany (Deutschland)+49
  • India (भारत)+91
  • United States+1
✓ Valid
  • Home
  • News
  • Requests
  • Disclaimer
OpenEquity Research

© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.

Would you like to meet the CEO?
No Result
View All Result
  • Home
  • News
  • Requests
  • Disclaimer

© 2022 OpenEquity Research - Investment-Grade Research for the rest of us.